156 related articles for article (PubMed ID: 34102284)
1. Oncostatin M promotes hepatic progenitor cell activation and hepatocarcinogenesis via macrophage-derived tumor necrosis factor-α.
Yang X; Shao C; Duan L; Hou X; Huang Y; Gao L; Zong C; Liu W; Jiang J; Ye F; Shi J; Zhao Q; Wu D; Wei L
Cancer Lett; 2021 Oct; 517():46-54. PubMed ID: 34102284
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis.
Di Maira G; Foglia B; Napione L; Turato C; Maggiora M; Sutti S; Novo E; Alvaro M; Autelli R; Colombatto S; Bussolino F; Carucci P; Gaia S; Rosso C; Biasiolo A; Pontisso P; Bugianesi E; Albano E; Marra F; Parola M; Cannito S
J Pathol; 2022 May; 257(1):82-95. PubMed ID: 35064579
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts constitutes the hepatocarcinogenesis-associated microenvironment.
Liu WT; Jing YY; Gao L; Li R; Yang X; Pan XR; Yang Y; Meng Y; Hou XJ; Zhao QD; Han ZP; Wei LX
Cell Death Differ; 2020 Jan; 27(1):85-101. PubMed ID: 31065105
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-α promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells.
Jing Y; Sun K; Liu W; Sheng D; Zhao S; Gao L; Wei L
Cancer Lett; 2018 Oct; 434():22-32. PubMed ID: 29981431
[TBL] [Abstract][Full Text] [Related]
5. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
6. Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation.
Yamashita T; Honda M; Nio K; Nakamoto Y; Yamashita T; Takamura H; Tani T; Zen Y; Kaneko S
Cancer Res; 2010 Jun; 70(11):4687-97. PubMed ID: 20484035
[TBL] [Abstract][Full Text] [Related]
7. The phospholipase A2 activity of peroxiredoxin 6 promotes cancer cell death induced by tumor necrosis factor alpha in hepatocellular carcinoma.
Xu X; Lu D; Zhuang R; Wei X; Xie H; Wang C; Zhu Y; Wang J; Zhong C; Zhang X; Wei Q; He Z; Zhou L; Zheng S
Mol Carcinog; 2016 Sep; 55(9):1299-308. PubMed ID: 26293541
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of growth and induction of differentiation of SMMC-7721 human hepatocellular carcinoma cells by Oncostatin M.
Kong N; Zhang XM; Wang HT; Mu XP; Han HZ; Yan WQ
Asian Pac J Cancer Prev; 2013; 14(2):747-52. PubMed ID: 23621231
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M causes liver fibrosis by regulating cooperation between hepatic stellate cells and macrophages in mice.
Matsuda M; Tsurusaki S; Miyata N; Saijou E; Okochi H; Miyajima A; Tanaka M
Hepatology; 2018 Jan; 67(1):296-312. PubMed ID: 28779552
[TBL] [Abstract][Full Text] [Related]
10. Monocyte-dependent oncostatin M and TNF-alpha synergize to stimulate unopposed matrix metalloproteinase-1/3 secretion from human lung fibroblasts in tuberculosis.
O'Kane CM; Elkington PT; Friedland JS
Eur J Immunol; 2008 May; 38(5):1321-30. PubMed ID: 18398932
[TBL] [Abstract][Full Text] [Related]
11. Tumor-derived adenosine promotes macrophage proliferation in human hepatocellular carcinoma.
Wang J; Wang Y; Chu Y; Li Z; Yu X; Huang Z; Xu J; Zheng L
J Hepatol; 2021 Mar; 74(3):627-637. PubMed ID: 33137360
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor ETV4 promotes the development of hepatocellular carcinoma by driving hepatic TNF-α signaling.
Qi D; Lu M; Xu P; Yao X; Chen Y; Gan L; Li Y; Cui Y; Tong X; Liu S; Zhao J; Liu N; Ye X
Cancer Commun (Lond); 2023 Dec; 43(12):1354-1372. PubMed ID: 37670477
[TBL] [Abstract][Full Text] [Related]
13.
Tan B; Luo W; Shen Z; Xiao M; Wu S; Meng X; Wu X; Yang Z; Tian L; Wang X
Scand J Gastroenterol; 2019 Apr; 54(4):432-440. PubMed ID: 30946611
[No Abstract] [Full Text] [Related]
14. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
[TBL] [Abstract][Full Text] [Related]
15. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo model exhibits protective effects of sesamin against destruction of cartilage induced with a combination of tumor necrosis factor-alpha and oncostatin M.
Khansai M; Boonmaleerat K; Pothacharoen P; Phitak T; Kongtawelert P
BMC Complement Altern Med; 2016 Jul; 16():205. PubMed ID: 27400672
[TBL] [Abstract][Full Text] [Related]
17. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
[TBL] [Abstract][Full Text] [Related]
18. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
[TBL] [Abstract][Full Text] [Related]
19. Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment.
Li Q; Ma L; Shen S; Guo Y; Cao Q; Cai X; Feng J; Yan Y; Hu T; Luo S; Zhou L; Peng B; Yang Z; Hua Y
J Exp Clin Cancer Res; 2019 Jul; 38(1):303. PubMed ID: 31296243
[TBL] [Abstract][Full Text] [Related]
20. M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis.
Shrivastava R; Asif M; Singh V; Dubey P; Ahmad Malik S; Lone MU; Tewari BN; Baghel KS; Pal S; Nagar GK; Chattopadhyay N; Bhadauria S
Cytokine; 2019 Jun; 118():130-143. PubMed ID: 29625858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
